The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
Open accessAbstract
Diabetic retinopathy (DR) is a common and devastating microvascular complication of diabetes and a major cause of acquired blindness in young adults. Advanced glycation end products (AGEs) accumulated under hyperglycemic conditions are thought to play an important role in the pathogenesis of DR. AGEs can exert their deleterious effects by acting directly to induce aberrant crosslinking of extracellular matrix proteins, to increase vascular stiffness, altering vascular structure and function. Moreover, AGEs binding to the receptor for AGEs (RAGE) evokes intensive intracellular signaling cascades that leading to endothelial dysfunction, elaboration of key proinflammatory cytokines and proangiogenic factors, mediating pericyte apoptosis, vascular inflammation and angiogenesis, as well as breakdown of the inner blood-retinal barrier (BRB), the end result of all these events is damage to the neural and vascular components of the retina. Elucidation of AGE-induced mechanisms will help in the understanding of the complex cellular and molecular pathogenesis associated with DR. Novel anti-AGEs agents or AGE crosslink “breakers” are being investigated, it is hoped that in next few years, some of these promising therapies will be successfully applied in clinical context, aiming to reduce the major economical and medical burden caused by DR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In blood vessels, accumulated AGEs also interact with mononuclear, endothelial, and smooth muscle cells, resulting in cellular dysfunction, tissue damage, and atherosclerosis development55–57,59.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
In the citing paper
“AGEs play important roles in diabetic microvascular complications by cross-linking with extracellular matrix proteins, thereby altering vascular elasticity, structure, and function56.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
In the citing paper
“The accumulation and exposure to AGEs exacerbate oxidative stress and inflammation and initiate the oxidation of low-density lipoproteins (LDLs), which are harmful to cardiovascular function.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
In the citing paper
“In addition, the AGE-RAGE interaction further instigates pericyte apoptosis, vascular inflammation and permeability, and blood-tissue barrier breakdown56.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
In the citing paper
“Endogenous and exogenous AGEs provoke the initiation and progression of NAFLD.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
In the citing paper
“The aggregation of AGEs decreases the levels of the most important cellular antioxidant peptides, glutathione (GSH), SIRT1, and tissue inhibitor of metalloproteinase 3 (TIMP3), accompanied by increased oxidative stress and inflammation, promoting inflammatory liver injury and fibrosis in experimental animal models and NAFLD patients55–57,124–126.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [56]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Lang, G. E., Vaiser, A., Snyder, W. B., & Lynn, J. R. (2007) · Developments in ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,607
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,178
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Klaassen, I., Noorden, C. J. F. V., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 738
Epidemiology of diabetic retinopathy and macular oedema: A systematic review
Williams, R., Airey, M., Baxter, H., Forrester, J., Kennedy-Martin, T., & Girach, A. (2004) · Eye · doi:10.1038/sj.eye.6701476 · Cited by 472
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K., Thorpe, S. R., Baynes, J., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Romeo, G. R., Liu, W.-H., Asnaghi, V., Kern, T. S., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2241 · Cited by 413
Basta, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.025 · Cited by 361
Cited by
Sorted by citations
Twarda‐Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 829
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
Lin, K., Hsih, W., Lin, Y., Wen, C., & Chang, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13480 · Cited by 446
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
Rodríguez, M. L., Pérez, S., Mena, S., Desco, C., & Ortega, Á. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4940825 · Cited by 234
Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105115 · Cited by 217
Endothelial Dysfunction in Diabetic Retinopathy
Gui, F., You, Z., Fu, S., Wu, H., & Zhang, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00591 · Cited by 230
Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
Mengstie, M. A., Abebe, E. C., Teklemariam, A. B., Mulu, A. T., Agidew, M. M., Azezew, M. T., Zewde, E. A., & Teshome, A. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1002710 · Cited by 232
Nawaz, M. I., Rezzola, S., Cancarini, A., Russo, A., Costagliola, C., Semeraro, F., & Presta, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.03.002 · Cited by 195
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Thakur, S., Gupta, S. K., Ali, V., Singh, P., & Verma, M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01343-5 · Cited by 159
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease
Lai, S. W. T., Gonzalez, E. D. J. L., Zoukari, T., Ki, P., & Shuck, S. C. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00160 · Cited by 154
The ECM: To Scaffold, or Not to Scaffold, That Is the Question
Valdoz, J. C., Johnson, B. C., Jacobs, D. J., Franks, N. A., Dodson, E. L., Sanders, C., Cribbs, C. G., & Ry, P. M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312690 · Cited by 156
Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
Mrugacz, M., Bryl, A., & Zorena, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030458 · Cited by 152
Sinclair, S. H., & Schwartz, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00843 · Cited by 153
Wdowiak, K., Walkowiak, J., Pietrzak, R., Bazan‐Wozniak, A., & Cielecka‐Piontek, J. (2022) · Nutrients · doi:10.3390/nu14132647 · Cited by 124
Nutraceuticals for the Treatment of Diabetic Retinopathy
Rossino, M. G., & Casini, G. (2019) · Nutrients · doi:10.3390/nu11040771 · Cited by 113
Clinical/Translational Aspects of Advanced Glycation End-Products
Zeng, C., Li, Y., Ma, J., Niu, L., & Tay, F. R. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.005 · Cited by 107
Enzymatic and non-enzymatic crosslinks found in collagen and elastin and their chemical synthesis
Gaar, J., Naffa, R., & Brimble, M. A. (2020) · Organic Chemistry Frontiers · doi:10.1039/d0qo00624f · Cited by 109
Metabolic Dysregulation and Neurovascular Dysfunction in Diabetic Retinopathy
Yumnamcha, T., Guerra, M. H., Singh, L. P., & Ibrahim, A. S. (2020) · Antioxidants · doi:10.3390/antiox9121244 · Cited by 103
Microglia in retinal angiogenesis and diabetic retinopathy
Hu, A., Schmidt, M. H. H., & Heinig, N. (2024) · Angiogenesis · doi:10.1007/s10456-024-09911-1 · Cited by 113
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
Leley, S. P., Ciulla, T. A., & Bhatwadekar, A. D. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s297494 · Cited by 100
Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
Oshitari, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032927 · Cited by 101
Advanced Glycation End Products in Disease Development and Potential Interventions
Zhang, Y., Zhang, Z., Tu, C., Chen, X., & He, R. (2025) · Antioxidants · doi:10.3390/antiox14040492 · Cited by 117
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Mahajan, N., Arora, P., & Sandhir, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8458472 · Cited by 88
Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa
Gallenga, C. E., Lonardi, M., Pacetti, S., Violanti, S. S., Tassinari, P., Virgilio, F. D., Tognon, M. G., & Perri, P. (2021) · Antioxidants · doi:10.3390/antiox10060848 · Cited by 79
The Role of Müller Cells in Diabetic Macular Edema
Lai, D., Wu, Y., Shao, C., & Qiu, Q. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.10.8 · Cited by 80
Trotta, M. C., Maisto, R., Guida, F., Boccella, S., Luongo, L., Baltă, C., D’Amico, G., Herman, H., Hermenean, A. O., Bucolo, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211005 · Cited by 78
Neuroinflammation and neurodegeneration in diabetic retinopathy
Bianco, L., Arrigo, A., Aragona, E., Antropoli, A., Berni, A., Saladino, A., Parodi, M. B., & Bandello, F. M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.937999 · Cited by 76
Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
Sharma, A., Mittal, S., Aggarwal, R., & Chauhan, M. K. (2020) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00151-w · Cited by 83
Rezzola, S., Loda, A., Corsini, M., Semeraro, F., Annese, T., Presta, M., & Ribatti, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581288 · Cited by 75
Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy
Steinle, J. J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109687 · Cited by 59
Macrophage/microglia polarization for the treatment of diabetic retinopathy
Yao, Y., Li, J., Zhou, Y., Wang, S., Zhang, Z., Jiang, Q., & Li, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1276225 · Cited by 60
Oxidative Stress in Neutrophils: Implications for Diabetic Cardiovascular Complications
Johnson, J., Jaggers, R. M., Sreejit, G., Dahdah, A., Murphy, A. J., Hanssen, N. M. J., & Nagareddy, P. R. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0116 · Cited by 62
Wang, Y., Wang, L., Guo, H., Peng, Y., Nie, D., Mo, J., & Ye, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109699 · Cited by 53
Aly, R. H., Ahmed, A. E., Hozayen, W. G., Rabea, A. M., Ali, T. M., Askary, A. E., & Ahmed, O. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.609223 · Cited by 54
Cui, C., Li, Y., & Liu, Y. (2019) · Human Cell · doi:10.1007/s13577-019-00240-w · Cited by 49
Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models
Chen, L., Cui, Y., Li, B., Weng, J., Wang, W., Zhang, S., Huang, X., Guo, X., & Huang, Q. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00473.2019 · Cited by 46
Self-citationSulforaphane delays diabetes-induced retinal photoreceptor cell degeneration
Lv, J., Bao, S., Liu, T., Wei, L., Wang, D., Ye, W., Wang, N., Song, S., Li, J., Chudhary, M., et al. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03267-w · Cited by 47
Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
Aragonès, G., Rowan, S., Francisco, S. G., Yang, W., Weinberg, J., Taylor, A., & Bejarano, E. (2020) · Antioxidants · doi:10.3390/antiox9111062 · Cited by 48
The role of inflammation and neurodegeneration in diabetic macular edema
Starace, V., Battista, M., Brambati, M., Cavalleri, M., Bertuzzi, F., Amato, A., Lattanzio, R., Bandello, F. M., & Cicinelli, M. V. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211055963 · Cited by 45
Comprehensive analysis of angiogenesis-related genes and pathways in early diabetic retinopathy
Gu, C., Lhamo, T., Zou, C., Zhou, C., Su, T., Draga, D., Luo, D., Zheng, Z. J., Yin, L., & Qiu, Q. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00799-6 · Cited by 43
Su, Y., Shao, S., Lai, E. C., Lee, C., Hung, M., Lai, C., Hsu, S., & Hung, J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14445 · Cited by 42
Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy
Oshitari, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010439 · Cited by 45
Recent advances in the management of diabetic retinopathy
Dulull, N. K., Kwa, F. A. A., Osman, N., Rai, U., Shaikh, B., & Thrimawithana, T. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.028 · Cited by 41
Lahoti, S., Nashawi, M., Sheikh, O., Massop, D., Mir, M., & CHILTON, R. J. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000209 · Cited by 40
Martínez‐Alberquilla, I., Gasull, X., Pérez-Luna, P., Seco-Mera, R., Ruiz‐Alcocer, J., & Crooke, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101553 · Cited by 35
Takayanagi, Y., Yamanaka, M., Fujihara, J., Matsuoka, Y., Gohto, Y., Obana, A., & Tanito, M. (2020) · Antioxidants · doi:10.3390/antiox9111100 · Cited by 34
Munjral, S., Maindarkar, M. A., Ahluwalia, P., Puvvula, A., Jamthikar, A. D., Jujaray, T., Suri, N., Paul, S., Pathak, R., Saba, L., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051234 · Cited by 36
RAGE plays key role in diabetic retinopathy: a review
Lu, Z., Fan, B., Li, Y., & Zhang, Y. (2023) · BioMedical Engineering OnLine · doi:10.1186/s12938-023-01194-9 · Cited by 33
Santos, F. M., Ciordia, S., Mesquita, J., Sousa, J. P. C., Paradela, A., Tomaz, C. T., & Passarinha, L. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04670-y · Cited by 38
Donato, L., Scimone, C., Alibrandi, S., Nicocia, G., Rinaldi, C., Sidoti, A., & D’Angelo, R. (2020) · Antioxidants · doi:10.3390/antiox9050416 · Cited by 32
Parveen, A., Sultana, R., Lee, S. M., Kim, T. H., & Kim, S. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01323-9 · Cited by 32
Santos, F. M., Mesquita, J., Sousa, J. P. C., Ciordia, S., Paradela, A., & Tomaz, C. T. (2022) · Antioxidants · doi:10.3390/antiox11030505 · Cited by 32
Revealing Advanced Glycation End Products Associated Structural Changes in Serum Albumin
Naftaly, A., Izgilov, R., Omari, E., & Benayahu, D. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00387 · Cited by 31
Frudd, K., Sivaprasad, S., Raman, R., Krishnakumar, S., Revathy, Y. R., & Turowski, P. (2021) · Acta Ophthalmologica · doi:10.1111/aos.14954 · Cited by 29
Rezaei, M., Rabizadeh, S., Mirahmad, M., Hajmiri, M. S., Nakhjavani, M., Hemmatabadi, M., & Shirzad, N. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00895-w · Cited by 29
The role of the mTOR pathway in diabetic retinopathy
Casciano, F., Zauli, E., Rimondi, E., Mura, M., Previati, M., Busin, M., & Zauli, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.973856 · Cited by 29
Rohilla, M., Rishabh, R., Bansal, S., Garg, A., Dhiman, S., Dhankhar, S., Saini, M., Chauhan, S., Alsubaie, N., Batiha, G. E., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115881 · Cited by 29
Zhang, J., Li, S., Zhang, S., Wang, Y., Jin, S., Zhao, C., Yang, W., Liu, Y., & Kong, G. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.01.006 · Cited by 28
Diabetic retinopathy: emerging concepts of current and potential therapy
Sadikan, M. Z., & Nasir, N. A. A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02599-y · Cited by 28
Natural plant medications for the treatment of retinal diseases: The blood-retinal barrier as a clue
Ren, Y., Liang, H., Xie, M., & Zhang, M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155568 · Cited by 33
Liu, Z., Zhu, H., Ma, Y., Tang, Z., Zhao, N., Wang, Y., & Pan, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154710 · Cited by 26
Silymarin reduces retinal microvascular damage in streptozotocin-induced diabetic rats
Karimi, R., Bakhshi, A., Dayati, P., Abazari, O., Shahidi, M., Savaee, M., Kafi, E., Rahmanian, M., & Naghib, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-20297-2 · Cited by 26
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis
Padovani-Claudio, D. A., Ramos, C. J., Capozzi, M. E., & Penn, J. S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101151 · Cited by 27
Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation
He, M., Long, P., Guo, L., Zhang, M., Wang, S., & He, H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/5376439 · Cited by 24
Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?
Yempén, R. E. A., Venzel, R., Campos, M. C. P., de Oliveira, L. P., Lins, R. V. D., Pessoni, A. M., Fanaro, G. B., Souza, A. D. O., Calaza, K. D. C., Alves, J. L. D. B., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120060 · Cited by 22
Yu, Y., Zhu, Z., Xie, M., Deng, L., Xie, X., & Zhang, M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114800 · Cited by 22
Kanta, J., Zavaďáková, A., Sticová, E., & Dubský, M. (2022) · International Wound Journal · doi:10.1111/iwj.13997 · Cited by 22
Zhang, S., Hu, J., Liu, X., Chen, L., Chen, H., Guo, X., & Huang, Q. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603450 · Cited by 23
Self-citationLin, D., Qin, R., & Guo, L. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30563 · Cited by 21
Portillo, J. C., Pfaff, A., Vos, S., Weng, M., Nagaraj, R. H., & Subauste, C. S. (2024) · Cells · doi:10.3390/cells13050429 · Cited by 21
Adropin as an indicator of T2DM and its complications
Zhang, H., & Chen, N. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.002 · Cited by 19
Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy
Tang, S., An, X., Sun, W., Zhang, Y., Yang, C., Kang, X., Sun, Y., Jiang, L., Zhao, X., Gao, Q., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1336123 · Cited by 23
Francisqueti‐Ferron, F. V., Ferron, A. J. T., Altomare, A., Garcia, J. L., Moreto, F., Ferreira, A. L. A., Minatel, I. O., Aldini, G., & Corrêa, C. R. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2021-0002 · Cited by 18
Ahuja, P., Waris, A., Siddiqui, S. S., & Mukherjee, A. K. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00297-5 · Cited by 18
Kaushik, V., Gessa, L., Kumar, N., & Fernandes, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054408 · Cited by 22
Yamazaki, Y., Wake, H., Nishinaka, T., Hatipoğlu, Ö. F., Liu, K., Watanabe, M., Toyomura, T., Mori, S., Yoshino, T., Nishibori, M., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112857 · Cited by 18
Abokyi, S., & Tse, D. Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-02033 · Cited by 17
Modulation of Oxidative Stress in Diabetic Retinopathy: Therapeutic Role of Natural Polyphenols
Gómez-Jiménez, V., Matas, R. B.-S. D. L., & Ortega, Á. (2025) · Antioxidants · doi:10.3390/antiox14070875 · Cited by 21
Trotta, M. C., Gesualdo, C., Petrillo, F., Cavasso, G., Corte, A. D., D’Amico, G., Hermenean, A. O., Simonelli, F., & Rossi, S. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.3.16 · Cited by 18
Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin
He, L., Liu, Y., Xu, J., Li, J., Cheng, G., Cai, J., Dang, J., Yu, M., Wang, W., Duan, W., et al. (2022) · Molecules · doi:10.3390/molecules27206995 · Cited by 17
Self-citationRAGE: A potential therapeutic target during FGF1 treatment of diabetes‐mediated liver injury
Zheng, P., Tang, Z., Xiong, J., Wang, B., Xu, J., Chen, L., Cai, S., Wu, C., Ye, L., Xu, K., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16446 · Cited by 18
Self-citationClinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers
Liu, C., Chen, H., Ma, Y., Zhang, L., Chen, L., Huang, J., Zhao, Z., Jiang, H., & Kong, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501305 · Cited by 16
Self-citationLiu, S., Chen, C., Ning, J., Ding, P., Chen, Y., Xie, T., Yang, H., Yan, X., & Han, J. (2025) · Visual Neuroscience · doi:10.48130/vns-0025-0012 · Cited by 21
Updates on medical and surgical managements of diabetic retinopathy and maculopathy
Chen, Y., Radke, N. V., Amarasekera, S., Park, D. H., Chen, N., Chhablani, J. K., Wang, N., Wu, W., Ng, D. S., Bhende, P., et al. (2025) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2025.100180 · Cited by 17
Takino, J.-I., Sato, T., Kanetaka, T., Okihara, K., Nagamine, K., Takeuchi, M., & Hori, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-82619-0 · Cited by 16
Exploring the recent molecular targets for diabetes and associated complications
Gupta, A. K., Behl, T., Sehgal, A., Bhardwaj, S., Singh, S., Sharma, N., & Hafeez, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06294-0 · Cited by 17
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Liu, X., Zhang, N., Zhang, S., & Xu, P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15502 · Cited by 16
Sahu, N., Singh, N. K., Arya, K. R., Reddy, S. S., Rai, A. K., Shukla, V., Pandey, J., Narender, T., Tamrakar, A. K., Kumar, B. N., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1073327 · Cited by 16
Hernández, C., Porta, M., Bandello, F. M., Grauslund, J., Harding, S. P., Aldington, S. J., Egan, C. A., Frydkjær-Olsen, U., García‐Arumí, J., Gibson, J. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041233 · Cited by 15
Liang, H., Ren, Y., Huang, Y., Xie, X., & Zhang, M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118078 · Cited by 15
Khedher, M. R. B., Hafsa, J., Haddad, M., & Hammami, M. (2020) · Plant Foods for Human Nutrition · doi:10.1007/s11130-020-00838-8 · Cited by 15
Kingsbury, K. D., Skeie, J. M., Cosert, K. M., Schmidt, G. A., Aldrich, B. T., Sáles, C. S., Weller, J. M., Kruse, F. E., Thomasy, S. M., Schlötzer-Schrehardt, U. M., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.7.26 · Cited by 14
Glycative stress as a cause of macular degeneration
Bejarano, E., Domenech‐Bendaña, A., Avila-Portillo, N., Rowan, S., Edirisinghe, S., & Taylor, A. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101260 · Cited by 15
Nutrients and Natural Substances for Hypoglycemic Effects and Management in Diabetic Retinopathy
Cappellani, F., Foti, R., Malaguarnera, G., D’Esposito, F., Musumeci, C., Rapisarda, L., Tognetto, D., Gagliano, C., & Zeppieri, M. (2025) · Nutrients · doi:10.3390/nu17071207 · Cited by 14
Nanomedicine for Treating Diabetic Retinopathy Vascular Degeneration
Borodina, T. N., Kostyushev, D. S., Zamyatnin, A. A., & Parodi, A. (2021) · International Journal of Translational Medicine · doi:10.3390/ijtm1030018 · Cited by 16
Burman, M. D., Bag, S., Ghosal, S., & Bhowmik, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00684 · Cited by 14
Weigand, M., Hauck, S. M., Deeg, C. A., & Degroote, R. L. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103989 · Cited by 15
Yamaguchi, H., Nagai, M., Sugawa, H., Yasuda, H., & Nagai, R. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09957-5 · Cited by 13
Diabetes-related perturbations in the integrity of physiologic barriers
Mooradian, A. D. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108552 · Cited by 12
Metadata
- Authors
- Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J.
- Affiliations
- Nanfang Hospital (CN)
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 48
- Issue
- 2
- Pages
- 705-717
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2883415922
- Cited by
- 204
- References
- 73
- Citations by year
- 2026: 13 · 2025: 28 · 2024: 21 · 2023: 28 · 2022: 35 · 2021: 33 · 2020: 31 · 2019: 14 · 2018: 1
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cellular Physiology and Biochemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Science and Technology Planning Project of Guangdong Province
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetic retinopathy, advanced glycation end products, receptor for advanced glycation end products, hyperglycemia, extracellular matrix cross-linking, vascular stiffness, endothelial dysfunction, pericyte apoptosis, angiogenesis, vascular inflammation, blood-retinal barrier breakdown, retinal microvascular complications
- MeSH terms
- Receptor for Advanced Glycation End Products, Blood-Retinal Barrier, Diabetic Retinopathy, Humans, Glycation End Products, Advanced, Reactive Oxygen Species, Vascular Endothelial Growth Factor A, Endoplasmic Reticulum Stress, Tight Junction Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
